pandem
influenza
viru
dissemin
global
identifi
mexico
unit
state
april
novel
swineorigin
influenza
viru
investig
team
due
sustain
widespread
humantohuman
transmiss
world
health
organ
rais
pandem
alert
level
phase
june
unlik
season
influenza
peopl
year
age
infect
preferenti
worldwid
world
health
organ
unusu
high
rate
sever
respiratori
diseas
mortal
among
young
patient
mexico
chowel
et
al
phenomenon
may
attribut
lack
preexist
crossreact
antibodi
pandem
viru
age
group
center
diseas
control
prevent
contrari
individu
preexist
antibodi
prevail
season
influenza
viru
apart
cross
reactiv
antibodi
level
viral
load
profil
differ
bodi
site
also
import
predict
diseas
sever
transmiss
viral
infect
hayden
et
al
chu
et
al
hung
et
al
cheng
et
al
de
jong
et
al
lowen
et
al
correl
virolog
profil
clinic
characterist
pandem
viru
infect
would
provid
import
knowledg
epidemiolog
control
clinic
manag
term
antivir
therapi
infect
control
measur
clinic
specimen
respiratori
secret
taken
nasopharyng
aspir
nasopharyngealthroat
swab
serum
urin
stool
collect
patient
clinic
suspicion
pandem
viru
infect
hong
kong
serial
sampl
respiratori
specimen
conduct
hospit
upon
outpati
followup
archiv
respiratori
specimen
patient
season
influenza
viru
infect
year
select
histor
control
patient
record
review
determin
demograph
clinic
inform
total
nucleic
acid
extract
perform
use
nuclisen
easymag
instrument
biomerieux
boxtel
netherland
accord
manufactur
instruct
briefli
ml
clinic
specimen
ad
ml
lysi
buffer
incub
min
room
temperatur
lyse
sampl
transfer
well
plastic
vessel
ml
silica
follow
automat
magnet
separ
nucleic
acid
recov
ml
elut
buffer
chan
et
al
diagnosi
pandem
viru
perform
quantit
revers
transcriptasepolymeras
chain
reaction
rtpcr
use
primer
target
hemagglutinin
gene
pandem
viru
quantit
pandem
viru
season
influenza
viru
perform
use
quantit
rtpcr
target
influenza
viru
gene
describ
previous
chan
et
al
lau
et
al
briefli
ml
elut
rna
influenza
viru
use
cdna
invitrogen
superscript
ii
kit
random
primer
describ
cdna
amplifi
lightcycl
instrument
faststart
dna
master
sybr
green
mix
reagent
kit
roch
diagnost
gmbh
mannheim
germani
typic
reaction
ml
cdna
amplifi
ml
lcpcr
master
mix
contain
faststart
dna
master
sybr
green
mix
mm
mgcl
mm
primer
determin
specif
assay
pcr
product
subject
melt
curv
analysi
per
second
end
assay
quantit
assay
refer
standard
prepar
use
pcriitopo
vector
invitrogen
san
diego
ca
contain
correspond
target
viral
sequenc
seri
log
dilut
equival
copi
per
reaction
prepar
gener
calibr
curv
run
parallel
test
sampl
specimen
result
outsid
upper
limit
expect
rang
extract
sampl
repeat
suitabl
dilut
detect
limit
assay
copi
rna
per
millilit
viral
cultur
madindarbi
canin
kidney
mdck
cell
monolay
cultur
tube
inocul
ml
clinic
sampl
describ
previous
yuen
et
al
examin
daili
cytopath
effect
cpe
direct
immunofluores
test
specif
antibodi
influenza
viru
nucleoprotein
done
fix
cell
smear
cpe
appear
end
incub
period
comparison
made
patient
pandem
viru
season
influenza
viru
infect
regard
demograph
underli
diseas
present
symptom
total
white
blood
cell
count
absolut
lymphocyt
count
initi
pretreat
viral
load
respiratori
specimen
day
diagnosi
among
patient
pandem
viru
infect
paramet
compar
longer
durat
day
shorter
durat
day
viral
shed
defin
time
onset
symptom
last
posit
sampl
rtpcr
underli
diseas
chronic
immunosuppress
state
includ
autoimmun
diseas
malign
diabet
mellitu
solid
organ
transplant
chronic
pulmonari
diseas
includ
asthma
chronic
obstruct
pulmonari
diseas
statist
analysi
perform
fisher
exact
test
categor
variabl
mannwhitney
utest
continu
variabl
univari
linear
regress
analysi
employ
determin
correl
age
durat
viral
shed
age
fecal
viral
load
twotail
pvalu
consid
signific
twentytwo
patient
diagnos
pandem
viru
infect
period
april
june
includ
studi
respiratori
specimen
posit
influenza
viru
gene
pandem
viru
gene
rtpcr
total
respiratori
specimen
collect
day
diagnosi
day
diagnosi
three
serial
respiratori
specimen
obtain
patient
within
initi
day
diagnosi
respiratori
specimen
collect
patient
day
reason
refus
due
either
discomfort
associ
procedur
improv
symptom
stool
urin
serum
specimen
avail
patient
respect
patient
pandem
viru
infect
receiv
oseltamivir
except
girl
oseltamivir
therapi
initi
day
day
day
diagnosi
fortyfour
patient
season
influenza
viru
infect
time
admiss
year
select
histor
control
randomli
none
receiv
antivir
therapi
cough
vomit
diarrhea
durat
symptom
diagnosi
significantli
differ
patient
pandem
viru
season
influenza
viru
infect
tabl
demograph
underli
diseas
initi
pretreat
viral
load
significantli
differ
two
group
pandem
case
season
influenza
histor
control
respiratori
specimen
collect
day
onset
symptom
day
highest
mean
viral
load
fig
tendenc
lower
initi
viral
load
pandem
case
though
serial
sampl
patient
obviou
decreas
trend
initi
viral
load
log
day
onset
symptom
log
third
day
onset
symptom
season
influenza
viru
infect
decreas
trend
revers
day
onset
symptom
sinc
pandem
case
diagnos
day
onset
symptom
direct
comparison
two
group
possibl
day
viral
load
respiratori
specimen
pandem
case
correl
neg
time
onset
symptom
r
p
shown
figur
median
durat
viral
shed
onset
symptom
day
two
patient
viral
shed
day
onset
symptom
among
patient
receiv
oseltamivir
patient
last
posit
rtpcr
respiratori
specimen
still
receiv
oseltamivir
median
durat
viral
shed
day
onset
symptom
remain
two
patient
last
posit
rtpcr
specimen
day
last
dose
oseltamivir
viral
shed
day
onset
symptom
among
patient
viral
shed
day
patient
neg
rtpcr
day
onset
symptom
four
patient
respiratori
specimen
obtain
day
onset
symptom
low
viral
load
copiesml
day
onset
symptom
younger
age
correl
longer
period
viral
shed
onset
symptom
r
p
apart
age
signific
differ
patient
shorter
longer
durat
viral
shed
regard
present
symptom
underli
diseas
blood
test
initi
pretreat
viral
load
tabl
ii
viral
cultur
initi
respiratori
specimen
posit
patient
pandem
viru
infect
rang
day
onset
symptom
except
one
patient
serial
viral
cultur
perform
patient
posit
cultur
day
onset
symptom
pandem
viru
detect
rtpcr
stool
four
nine
patient
age
year
old
posit
stool
specimen
obtain
day
onset
symptom
mean
viral
load
stool
copiesml
rang
copiesml
signific
correl
higher
viral
load
younger
age
r
p
viral
cultur
posit
stool
specimen
highest
viral
load
one
patient
detect
pandem
viru
urin
rtpcr
day
onset
symptom
neg
viral
cultur
none
avail
sera
collect
day
onset
symptom
detect
virus
rtpcr
boy
pandem
viru
infect
uniqu
sever
aspect
firstli
patient
detect
viral
shed
respiratori
specimen
stool
urin
secondli
viral
load
highest
among
patient
initi
pretreat
viral
load
respiratori
specimen
stool
urin
copiesml
respect
specimen
high
viral
load
collect
day
onset
symptom
wherea
j
med
virol
doi
patient
pandem
viru
detect
viral
load
data
provid
import
inform
regard
virushost
interact
peak
mean
viral
load
occur
earli
ill
pandem
viru
season
influenza
viru
infect
similar
studi
human
volunt
hayden
et
al
patient
present
hospit
day
onset
symptom
initi
pretreat
viral
load
pandem
case
lower
season
influenza
histor
control
might
explain
differ
sever
ill
less
upper
respiratori
tract
gastrointestin
symptom
found
pandem
case
sinc
hospit
despit
mild
symptom
contain
phase
pandem
control
hong
kong
mani
case
transfer
directli
airport
hospit
either
onset
symptom
flight
found
fever
bodi
temperatur
screen
upon
arriv
airport
moreov
respiratori
specimen
taken
everi
patient
suspect
pandem
viru
infect
independ
sever
symptom
underli
diseas
wherea
nonpandem
period
minor
patient
season
influenza
viru
infect
attend
hospit
servic
respiratori
specimen
collect
virolog
diagnosi
result
patient
select
randomli
histor
control
like
sever
symptom
chronic
underli
ill
associ
higher
initi
pretreat
viral
load
diagnosi
case
control
initi
pretreat
viral
load
lower
patient
longer
durat
symptom
hospit
howev
trend
extend
patient
attend
hospit
day
onset
symptom
boy
pandem
viru
infect
viral
load
except
high
day
onset
symptom
prolong
symptomat
phase
might
reflect
poor
host
immun
lead
higher
viral
load
observ
would
requir
verif
patient
data
futur
expect
viral
load
pandem
patient
decreas
gradual
onset
symptom
patient
immun
system
respond
infect
hayden
et
al
cheng
et
al
howev
signific
viral
shed
log
copiesml
still
present
day
onset
symptom
addit
younger
age
correl
longer
period
viral
shed
find
similar
previou
studi
season
influenza
viru
infect
viral
load
gener
low
undetect
day
ill
could
persist
day
children
world
health
organ
write
group
viral
load
found
especi
high
young
children
hall
et
al
prolong
shed
could
also
occur
immunocompromis
patient
antivir
therapi
also
proven
reduc
viral
shed
season
influenza
hayden
et
al
boivin
et
al
ward
et
al
howev
sinc
patient
seri
receiv
oseltamivir
effect
antivir
therapi
novel
strain
could
determin
studi
involv
patient
without
oseltamivir
therapi
would
necessari
assess
impact
antivir
treatment
viral
shed
clinic
outcom
pandem
viru
detect
stool
four
patient
posit
viral
cultur
specimen
highest
viral
load
previou
studi
show
human
influenza
viru
could
detect
stool
buchi
et
al
viru
demonstr
biopsi
small
larg
intestin
fatal
case
uiprasertkul
et
al
zhang
et
al
respiratori
virus
found
stool
includ
sar
coronaviru
respiratori
syncyti
viru
von
linstow
et
al
adenoviru
wilhelmi
et
al
bocaviru
lau
et
al
season
influenza
viru
detect
rtpcr
stool
report
young
children
age
week
month
posit
viral
cultur
report
wootton
et
al
find
fecal
shed
occur
patient
pandem
viru
infect
highlight
import
contact
precaut
handl
stool
especi
import
younger
children
higher
viral
load
stool
despit
presenc
gastrointestin
tract
none
case
develop
signific
gastrointestin
symptom
might
relat
small
sampl
size
rel
mild
infect
vomit
diarrhea
common
among
pandem
urinari
shed
pandem
viru
occur
previous
healthi
boy
appar
symptomat
phase
day
diagnosi
accompani
persist
high
viral
load
nasopharyng
aspir
fece
day
onset
symptom
although
influenza
viru
cultur
routin
kidney
cell
line
clinic
manifest
attribut
urinari
tract
tehran
patient
hemorrhag
cystiti
influenza
season
either
viru
isol
throat
swab
fourfold
rise
hemagglutin
inhibit
antibodi
titer
influenza
viru
khakpour
nikakhtar
seri
influenza
viru
isol
urin
three
patient
respiratori
virus
detect
urin
includ
adenoviru
hatakeyama
et
al
sar
coronaviru
lau
et
al
bocaviru
pozo
et
al
pandem
viru
detect
serum
sampl
might
relat
small
sampl
size
viremia
observ
blood
donor
without
symptom
recogn
although
uncommon
phenomenon
season
influenza
zou
liko
et
al
influenza
viru
infect
serum
level
prognost
signific
de
jong
et
al
studi
sever
limit
viral
load
differ
type
respiratori
specimen
might
affect
method
collect
nasopharyng
aspir
consid
gold
standard
obtain
nasopharyng
epitheli
cell
howev
nasopharyng
swab
nasopharyng
flock
swab
nosethroat
swab
suggest
altern
high
sensit
frayha
et
al
lambert
et
al
chan
et
al
patient
influenza
viru
infect
quantiti
viru
significantli
differ
nasopharyng
aspir
nasopharyng
flock
swab
chan
et
al
analysi
serial
viral
chang
might
also
affect
absenc
specimen
consecut
day
sinc
obtain
respiratori
specimen
associ
discomfort
mani
patient
refus
daili
specimen
collect
symptom
improv
virolog
profil
pandem
viru
infect
determin
extent
viral
shed
chang
viral
load
studi
provid
essenti
inform
design
manag
polici
fecal
urinari
shed
pandem
viru
especi
children
may
contribut
inadvert
humantohuman
transmiss
despit
emphasi
droplet
contact
precaut
respiratori
secret
sinc
prolong
shed
may
occur
despit
oseltamivir
therapi
routin
infect
control
measur
also
enforc
risk
period
prevent
outbreak
institut
